33 related articles for article (PubMed ID: 28766961)
1. HOXA13 is associated with unfavorable survival and acts as a novel oncogene in prostate carcinoma.
Dong Y; Cai Y; Liu B; Jiao X; Li ZT; Guo DY; Li XW; Wang YJ; Yang DK
Future Oncol; 2017 Jul; 13(17):1505-1516. PubMed ID: 28766961
[TBL] [Abstract][Full Text] [Related]
2. Survival of Hoxa13 homozygous mutants reveals a novel role in digit patterning and appendicular skeletal development.
Perez WD; Weller CR; Shou S; Stadler HS
Dev Dyn; 2010 Feb; 239(2):446-57. PubMed ID: 20034107
[TBL] [Abstract][Full Text] [Related]
3. Interplay between lncRNA/miRNA and Wnt/ß-catenin signaling in brain cancer tumorigenesis.
Rahmani F; Mohammed Al-Asady A; Hanaie R; Zandigohar M; Faridnejad H; Payazdan M; Safavi P; Ryzhikov M; Hassanian SM
EXCLI J; 2023; 22():1211-1222. PubMed ID: 38204968
[TBL] [Abstract][Full Text] [Related]
4. HOXC6: A promising biomarker linked to an immunoevasive microenvironment in colorectal cancer based on TCGA analysis and cohort validation.
Weng M; Lai Y; Ge X; Gu W; Zhang X; Li L; Sun M
Heliyon; 2024 Jan; 10(1):e23500. PubMed ID: 38192826
[No Abstract] [Full Text] [Related]
5. Hsa-microRNA-1249-3p/Homeobox A13 axis modulates the expression of β-catenin gene in human epithelial cells.
Mazziotta C; Iaquinta MR; Tramarin ML; Badiale G; Cervellera CF; Tonnini G; Patergnani S; Pinton P; Lanza G; Gafà R; Tognon M; Martini F; De Mattei M; Rotondo JC
Sci Rep; 2023 Dec; 13(1):22872. PubMed ID: 38129477
[TBL] [Abstract][Full Text] [Related]
6. Differential Protein Expression Patterns of HOXA13 and HOXB13 Are Associated with Bladder Cancer Progression.
Chin FW; Hussin H; Chau DM; Ong TA; Yunus R; Abdul Razack AH; Yusoff K; Chan SC; Veerakumarasivam A
Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627895
[TBL] [Abstract][Full Text] [Related]
7. An insight into the diagnostic and prognostic value of HOX A13's expression in non-muscle invasive bladder cancer.
Setti Boubaker N; Gurtner A; Trabelsi N; Manni I; Blel A; Saadi A; Chakroun M; Naimi Z; Zaghbib S; Ksontini M; Meddeb K; Rammeh S; Ayed H; Chebil M; Piaggio G; Ouerhani S
J Clin Lab Anal; 2022 Sep; 36(9):e24606. PubMed ID: 35853090
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer.
Song YP; Xian P; Luo H; Dai JY; Bai Y; Li Y; Tang XL
J Immunol Res; 2022; 2022():5740971. PubMed ID: 35372588
[TBL] [Abstract][Full Text] [Related]
9. A Review of Prostate Organogenesis and a Role for iPSC-Derived Prostate Organoids to Study Prostate Development and Disease.
Buskin A; Singh P; Lorenz O; Robson C; Strand DW; Heer R
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884905
[TBL] [Abstract][Full Text] [Related]
10. HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer.
Sekino Y; Pham QT; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Shiota M; Yasui W; Teishima J
Biomedicines; 2021 Jul; 9(8):. PubMed ID: 34440097
[TBL] [Abstract][Full Text] [Related]
11. Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients.
Cai J; Yang F; Chen X; Huang H; Miao B
Pharmgenomics Pers Med; 2021; 14():797-811. PubMed ID: 34285549
[TBL] [Abstract][Full Text] [Related]
12. HOXA13 in etiology and oncogenic potential of Barrett's esophagus.
Janmaat VT; Nesteruk K; Spaander MCW; Verhaar AP; Yu B; Silva RA; Phillips WA; Magierowski M; van de Winkel A; Stadler HS; Sandoval-Guzmán T; van der Laan LJW; Kuipers EJ; Smits R; Bruno MJ; Fuhler GM; Clemons NJ; Peppelenbosch MP
Nat Commun; 2021 Jun; 12(1):3354. PubMed ID: 34099670
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer.
Lu T; Tang J; Shrestha B; Heath BR; Hong L; Lei YL; Ljungman M; Neamati N
Theranostics; 2020; 10(15):6959-6976. PubMed ID: 32550915
[TBL] [Abstract][Full Text] [Related]
14. Paralogous HOX13 Genes in Human Cancers.
Botti G; Cillo C; De Cecio R; Malzone MG; Cantile M
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31137568
[TBL] [Abstract][Full Text] [Related]
15. An expanded variant list and assembly annotation identifies multiple novel coding and noncoding genes for prostate cancer risk using a normal prostate tissue eQTL data set.
DeRycke MS; Larson MC; Nair AA; McDonnell SK; French AJ; Tillmans LS; Riska SM; Baheti S; Fogarty ZC; Larson NB; O'Brien DR; Cheville JC; Wang L; Schaid DJ; Thibodeau SN
PLoS One; 2019; 14(4):e0214588. PubMed ID: 30958860
[TBL] [Abstract][Full Text] [Related]
16. Long Non-coding RNA DLEU1 Promotes Proliferation and Invasion by Interacting With miR-381 and Enhancing HOXA13 Expression in Cervical Cancer.
Liu C; Tian X; Zhang J; Jiang L
Front Genet; 2018; 9():629. PubMed ID: 30581456
[TBL] [Abstract][Full Text] [Related]
17. A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.
Capaia M; Granata I; Guarracino M; Petretto A; Inglese E; Cattrini C; Ferrari N; Boccardo F; Barboro P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966326
[TBL] [Abstract][Full Text] [Related]
18. The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.
Deng Y; He R; Zhang R; Gan B; Zhang Y; Chen G; Hu X
Oncol Lett; 2018 Jun; 15(6):8556-8572. PubMed ID: 29805592
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.
Shi Q; Shen L; Dong B; Fu H; Kang X; Dai L; Yang Y; Yan W; Chen KN
Thorac Cancer; 2018 Jul; 9(7):836-846. PubMed ID: 29757528
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
